Proteon Therapeutics Announces Review of Potential Strategic Transactions
April 15, 2019 16:30 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., April 15, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
LogistiCare and National Kidney Foundation Team-Up for Kidney Patients
April 03, 2019 14:38 ET
|
LogistiCare
ATLANTA, April 03, 2019 (GLOBE NEWSWIRE) -- LogistiCare, the nation’s largest non-emergency medical transportation broker, today announced it is teaming-up with the National Kidney Foundation (NKF)...
Proteon Therapeutics Announces Top-Line Results From Phase 3 PATENCY-2 Clinical Trial of Vonapanitase in Radiocephalic Arteriovenous Fistulas
March 28, 2019 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., March 28, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
LogistiCare Raises Public Awareness during National Kidney Month
March 19, 2019 11:45 ET
|
LogistiCare
ATLANTA, March 19, 2019 (GLOBE NEWSWIRE) -- In the United States, more than 661,000 people suffer from kidney failure. Of these, 468,000 individuals are on dialysis, and roughly 193,000 live with a...
On World Kidney Day, American Kidney Fund Urges Americans to Get Tested for Kidney Disease
March 14, 2019 10:58 ET
|
American Kidney Fund
ROCKVILLE, Md., March 14, 2019 (GLOBE NEWSWIRE) -- With kidney disease affecting 30 million Americans—most of whom are unaware they have it—the American Kidney Fund (AKF) is using today, World...
National Kidney Foundation of Illinois Names Jacqueline Burgess-Bishop, FACHE, Chief Executive Officer
March 13, 2019 11:41 ET
|
National Kidney Foundation of Illinois
Chicago, IL, March 13, 2019 (GLOBE NEWSWIRE) -- The Board of Directors of the National Kidney Foundation of Illinois (NKFI) is delighted to announce that it has unanimously chosen Jacqueline...
Proteon Therapeutics Announces Fourth Quarter and Full-Year 2018 Financial Results
March 13, 2019 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., March 13, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
Proteon Therapeutics to Present at the Cowen and Company 39th Annual Health Care Conference on March 11th
March 04, 2019 16:30 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq: PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Robert I. Schattner Foundation provides $150,000 grant to American Kidney Fund for children’s programs and financial assistance to dialysis patients in D.C. region
January 30, 2019 13:15 ET
|
American Kidney Fund
ROCKVILLE, Md., Jan. 30, 2019 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced a $150,000 grant from the Robert I. Schattner Foundation to help fund three programs—two that support...
Proteon Therapeutics Announces Publication of Results from Phase 3 PATENCY-1 Clinical Trial of Investigational Vonapanitase in Patients with Chronic Kidney Disease
January 24, 2019 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...